Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Histology and Histopathology|September 3, 2021
The differential expression of perilipin-2 in hepatoblastoma and its association with prognosisSadafumi Azukisawa, Jianbo Zheng, Xin Guo, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 6, 2021
TSC2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solitary subependymal giant cell astrocytomaTsuyoshi Sasaki, Takehiro Uda, Ichiro Kuki, et al.
International Journal of Molecular Sciences|February 26, 2025
Integrated Analysis of Somatic DNA Variants and DNA Methylation of Tumor Suppressor Genes in Colorectal CancerHisashi Nishiki, Hiroki Ura, Sumihito Togi, et al.
Respiratory Medicine Case Reports|October 27, 2021
Resolution of multifocal micronodular pneumocyte hyperplasia with everolimus in a patient with tuberous sclerosis complexTetsuaki Shoji, Yo Niida, Takahiro Osawa, et al.
Clinical Kidney Journal|June 12, 2015
Adult-onset renal failure in a family with Alagille syndrome with proteinuria and a novel JAG1 mutationNorifumi Hayashi, Hiroshi Okuyama, Yuki Matsui, et al.
The Journal of Biological Chemistry|September 13, 2002
The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeletonLuciana A Haddad, Nicole Smith, Mark Bowser, et al.
The Journal of Molecular Diagnostics : JMD|October 21, 2005
A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicismTomotsugu Ichikawa, Akiko Wakisaka, Shigeru Daido, et al.
Dermatology Reports|March 27, 2026
A case of hereditary hemorrhagic telangiectasia with ACVRL1 gene variantSawako Ochiai, Reimon Yamaguchi, Kiminobu Takeda, et al.
Congenital Anomalies|June 9, 2016
Cartilage-hair hypoplasia associated with isolated hypoganglionosis: A case reportYoshitomo Yasui, Miyuki Kohno, Syouichi Nishida, et al.
Frontiers in Oncology|June 26, 2020
Higher Tumor Mutation Burden and Higher PD-L1 Activity Predicts the Efficacy of Immune Checkpoint Inhibitor Treatment in a Patient With Four Lung Cancers. A Case ReportKatsuo Usuda, Yo Niida, Shun Iwai, et al.
Pageof 10